The impact of diagnostic delay on the course of septic shock caused by extended-spectrum-beta- lactamase-producing Escherichia coli.
Gashi
Musli
M
Raka
Lul
L
Ahmeti
Salih
S
Gashi
Sanije
S
Dika
Ardian
A
Gashi
Goneta
G
D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D042241:Early Diagnosis; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology / Q000302:isolation & purification*; D029968:Escherichia coli Proteins / Q000378:metabolism*; D006801:Humans; D008297:Male; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012772:Shock, Septic / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D013845:Thienamycins / Q000627:therapeutic use; D013997:Time Factors; D001618:beta-Lactamases / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D013845:Thienamycins; D002939:Ciprofloxacin; D001618:beta-Lactamases; D000077731:Meropenem; D002439:Cefotaxime